Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death

Z. A. Stewart, A. M. Cameron, A. L. Singer, R. A. Montgomery, D. L. Segev

Research output: Contribution to journal › Article › peer-review

101 Scopus citations

Fingerprint

Dive into the research topics of 'Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death'. Together they form a unique fingerprint.

Medicine & Life Sciences